Advancing innovation through collaboration: Aculeus and WEHI join forces

Since its inception, Aculeus has held the strong belief that the most effective way to bring new medicines to patients is by combining ‘industry-grade’ drug discovery science, with deep knowledge of biology and disease. In crisp alignment with this approach, Aculeus is proud to collaborate with scientists and clinicians at the Walter and Eliza Hall Institute of Medical Research (WEHI). Initiated in 2022, this partnership unites academic, clinical, and drug discovery expertise to inform and direct the Phase 1 clinical trial of ACU-0943 in patients with Acute Myeloid Leukemia (AML).